Mitchell P. Kopin 13D and 13G filings for Liminatus Pharma, Inc. Class A Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-20 4:15 pm Purchase | 2026-02-17 | 13G | LIMINATUS PHARMA INC LIMN | Mitchell P. Kopin | 2,065,885 4.990% | 2,065,885 (New Position) | Filing |